Episode
#7, S1 Trials & Treatment: Lobectomy vs Sublobar Resection for early-stage NSCLC
- Podcast
- Thinking Thoracic
- Published
- Mar 26, 2025
- Duration seconds
- 2043
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/thinking-thoracic-7116337/episodes/7-s1-trials-treatment-lobectomy-vs-sublobar-resection-for-early-stage-nsclc/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/thinking-thoracic-7116337/7-s1-trials-treatment-lobectomy-vs-sublobar-resection-for-early-stage-nsclc.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode of Thinking Thoracic, co-host Dr. Jeff Yang welcomes Dr. Gavitt Woodard and Dr. Christopher Seder to discuss their recent research on lobectomy versus sublobar resection for early-stage non-small cell lung cancer. Their studies, leveraging data from The STS General Thoracic Surgery Database, provide valuable insights into the long-term survival outcomes of these surgical approaches. Hear from Dr. Woodard on how her study, recognized as the Richard E. Clark Memorial Paper, aimed to evaluate patient populations that were not well represented in prior randomized trials, such as older adults and those with poorer pulmonary function. Dr. Seder explains how his research took a complementary approach, examining over 32,000 patients from 2012 to 2022, with a focus on distinguishing the survival outcomes between lobectomy, segmentectomy, and wedge resection. Listen today.